COMMUNIQUÉS West-GlobeNewswire

Nxera Pharma Announces Vamorolone Selected for South Korea’s Accelerated Reimbursement Pilot Program for Rare Disease Treatments
06/11/2026
Vamorolone is one of five treatments selected for the rare disease reimbursement pilot program. The program aims to shorten the National Health Insurance listing process to within 100 days. Together with GIFT priority [...]
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
06/11/2026
BASEL, Switzerland, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, [...]
Le KFSH de Riyad figure parmi les 5 % des meilleurs établissements de santé au monde pour le tourisme médical selon le classement 2027 de Newsweek
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad se classe parmi les 5 % des meilleurs établissements de santé répertoriés dans l’édition [...]
Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
06/11/2026
Australian fast-start pathway, four Centers of Excellence and a GlobalReady model that takes programs from first-in-human to global Phase II without changing CROs ADELAIDE, Australia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- [...]
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
06/11/2026
Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kg Joenja is expected to become available to patients covered by the expanded indication in February 2027 [...]
Orchestra BioMed Announces Pricing of Public Offering
06/11/2026
NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients [...]
Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion
06/11/2026
Second annual Congress at the Yale Club of New York City unites health system CEOs, physicians, technologists and investors; Healthcare Shark Tank led by Robert Herjavec fields 360+ startup applications from 35+ [...]
South San Jose Family Dentistry Launches Under New Owner Dr. Dillon Chang, Continuing 40 Years as a Family Dentist in San Jose
06/11/2026
Following Dr. Les M. Wong's retirement after 40 years at the Blossom Hill Road location, the practice formerly known as San Jose Smile Design has new ownership and a new name and brand, with the same location, phone [...]
MediPharm Labs Achieves Critical European Regulatory Milestone Supporting Commercialization of Proprietary Metered-Dose Cannabis Inhaler Platform
06/11/2026
Positive Article 117 Notified Body Opinion satisfies a key EU regulatory requirement for an advanced cannabis drug-device combination product and supports planned commercialization in the UK and Europe TORONTO, Nov. 05 [...]
Ossium Health to Present One-Year Outcomes in Highly Mismatched Organ Donor Bone Marrow Transplants at ASH 2026
06/11/2026
SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ossium Health, a bioengineering company that built the world's first bank of organ donor-derived bone marrow, today announced that four abstracts have been selected for [...]
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026
05/11/2026
SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday [...]
Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year
05/11/2026
FREMONT, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that its Cytek Aurora ® Evo system has been named Drug Discovery Innovation of the [...]
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
05/11/2026
Initial clinical data for NKX019 in idiopathic inflammatory myopathy (myositis) and systemic sclerosis (scleroderma) to be presented at ACR Convergence 2026 Cash balance of $216.0 million on September 30, 2026, [...]
Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study
05/11/2026
Company to host a conference call and audio webcast tomorrow at 8:00 a.m. ET TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage biotechnology company [...]
Tarsus to Participate in Upcoming Investor Conferences
05/11/2026
IRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Guggenheim 3 rd Annual [...]
BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
05/11/2026
First participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027 QUELL-CV, a Phase 2 [...]
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
05/11/2026
Infection is a Major Unmet Need in Plastic and Reconstructive Surgery: Infection risk was cited in all 11 breast research sessions at the American Society of Plastic Surgeons’ annual meeting, with serious infection [...]
CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
05/11/2026
- Varsetatug masetecan (Varseta-M) granted FDA Fast Track designation for relapsed/refractory metastatic colorectal cancer - - Phase 1 monotherapy data update in metastatic colorectal cancer (mCRC) expected in January [...]
Nephros Announces Strong Third Quarter 2026 Financial Results
05/11/2026
Year Over Year Net Revenue Growth of 18% and Core Programmatic Revenue Growth of 8% for the Three Months Ended September 30, 2026 SOUTH ORANGE, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a [...]

Pages